MIL •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/29/2026 09:46
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization410,426 mln
Float1,764 mln
Earnings Date07/31/2026
EPS
1.79
Stretched
P / E
130
Highly speculative
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.68
Likely reliable
Relative Strength
84
/ 100
Strongly outperforming
Debt / Equity
-10.95
Negative equity
Business Description
AbbVie is a global pharmaceutical company that develops, manufactures, and sells a wide range of medicines and therapies across multiple health areas. Its portfolio covers treatments for conditions including blood cancers, autoimmune and inflammatory diseases, neurological disorders, migraines, eye conditions, and digestive issues, among others. The company also operates in the aesthetics space, offering cosmetic injectables, skincare, and body contouring products. Founded in 2012 and based in North Chicago, Illinois, AbbVie serves patients in markets around the world.
